    <SEC-DOCUMENT>0001193125-26-220695-index.html : 20260513
    <SEC-HEADER>0001193125-26-220695.hdr.sgml : 20260513
    <ACCEPTANCE-DATETIME>20260513083322
    ACCESSION NUMBER:		0001193125-26-220695
    CONFORMED SUBMISSION TYPE:	ARS
    PUBLIC DOCUMENT COUNT:		1
    CONFORMED PERIOD OF REPORT:	20251231
    FILED AS OF DATE:		20260513
    DATE AS OF CHANGE:		20260513
    EFFECTIVENESS DATE:		20260513

    FILER:

    	COMPANY DATA:
    		COMPANY CONFORMED NAME:			Coya Therapeutics, Inc.
    		CENTRAL INDEX KEY:			0001835022
    		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
    		ORGANIZATION NAME:           	03 Life Sciences
    		EIN:				000000000
    		STATE OF INCORPORATION:			DE
    		FISCAL YEAR END:			1231

    	FILING VALUES:
    		FORM TYPE:		ARS
    		SEC ACT:		1934 Act
    		SEC FILE NUMBER:	001-41583
    		FILM NUMBER:		26971079

    	BUSINESS ADDRESS:
    		STREET 1:		12645 MEMORIAL DR., SUITE F1 #305
    		CITY:			HOUSTON
    		STATE:			TX
    		ZIP:			77024
    		BUSINESS PHONE:		650.739.3939

    	MAIL ADDRESS:
    		STREET 1:		12645 MEMORIAL DR., SUITE F1 #305
    		CITY:			HOUSTON
    		STATE:			TX
    		ZIP:			77024
    </SEC-HEADER>
    <DOCUMENT>
    <TYPE>ARS
    <SEQUENCE>1
    <FILENAME>d845755dars.pdf
    <DESCRIPTION>ARS
    <TEXT>
    Document 1 - file: d845755dars.pdf

    </DOCUMENT>
    </SEC-DOCUMENT>